Cargando…
Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy
BACKGROUND: Fournier’s gangrene is a necrotizing fasciitis of the genital and perineal region. It may progress, affecting the groin, the thigh, or even the abdominal wall. Despite adequate treatment (debridement and antibiotics), the mortality rate is very high, reaching 20–35%. Fournier’s gangrene...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158144/ https://www.ncbi.nlm.nih.gov/pubmed/30259251 http://dx.doi.org/10.1186/s40792-018-0526-0 |
_version_ | 1783358369050918912 |
---|---|
author | Kobayashi, Daigo Masubuchi, Mariko Takase, Tsunenobu Ichikawa, Takahiro Deguchi, Tomohiro Yaguchi, Toyohisa |
author_facet | Kobayashi, Daigo Masubuchi, Mariko Takase, Tsunenobu Ichikawa, Takahiro Deguchi, Tomohiro Yaguchi, Toyohisa |
author_sort | Kobayashi, Daigo |
collection | PubMed |
description | BACKGROUND: Fournier’s gangrene is a necrotizing fasciitis of the genital and perineal region. It may progress, affecting the groin, the thigh, or even the abdominal wall. Despite adequate treatment (debridement and antibiotics), the mortality rate is very high, reaching 20–35%. Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy is very rare. We report this case with a review of the literature. CASE PRESENTATION: A 68-year-old man visited the emergency room due to perineal pain during which he accepted the chemotherapy for locally advanced rectal cancer. Abdominal CT scan showed extensive emphysema in the scrotum and gluteus maximus muscle. We diagnosed as Fournier’s gangrene caused by penetration of a rectal cancer. We performed debridement, left orchiectomy, transverse colostomy with double orifices. Post-operative day 30, we performed abdominoperineal resection. We performed CapeOX therapy eight courses as adjuvant chemotherapy. The patient had no recurrence for 1 year and 2 months after the operation. CONCLUSIONS: Going forward, knowledge gained from this case will increase the opportunity to perform neoadjuvant chemotherapy for locally advanced rectal cancer. In medical treatment, we must put the possibility of Fournier’s gangrene in mind and treat as soon as possible. |
format | Online Article Text |
id | pubmed-6158144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-61581442018-10-12 Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy Kobayashi, Daigo Masubuchi, Mariko Takase, Tsunenobu Ichikawa, Takahiro Deguchi, Tomohiro Yaguchi, Toyohisa Surg Case Rep Case Report BACKGROUND: Fournier’s gangrene is a necrotizing fasciitis of the genital and perineal region. It may progress, affecting the groin, the thigh, or even the abdominal wall. Despite adequate treatment (debridement and antibiotics), the mortality rate is very high, reaching 20–35%. Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy is very rare. We report this case with a review of the literature. CASE PRESENTATION: A 68-year-old man visited the emergency room due to perineal pain during which he accepted the chemotherapy for locally advanced rectal cancer. Abdominal CT scan showed extensive emphysema in the scrotum and gluteus maximus muscle. We diagnosed as Fournier’s gangrene caused by penetration of a rectal cancer. We performed debridement, left orchiectomy, transverse colostomy with double orifices. Post-operative day 30, we performed abdominoperineal resection. We performed CapeOX therapy eight courses as adjuvant chemotherapy. The patient had no recurrence for 1 year and 2 months after the operation. CONCLUSIONS: Going forward, knowledge gained from this case will increase the opportunity to perform neoadjuvant chemotherapy for locally advanced rectal cancer. In medical treatment, we must put the possibility of Fournier’s gangrene in mind and treat as soon as possible. Springer Berlin Heidelberg 2018-09-26 /pmc/articles/PMC6158144/ /pubmed/30259251 http://dx.doi.org/10.1186/s40792-018-0526-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Case Report Kobayashi, Daigo Masubuchi, Mariko Takase, Tsunenobu Ichikawa, Takahiro Deguchi, Tomohiro Yaguchi, Toyohisa Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy |
title | Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy |
title_full | Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy |
title_fullStr | Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy |
title_full_unstemmed | Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy |
title_short | Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy |
title_sort | fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158144/ https://www.ncbi.nlm.nih.gov/pubmed/30259251 http://dx.doi.org/10.1186/s40792-018-0526-0 |
work_keys_str_mv | AT kobayashidaigo fourniersgangrenecausedbypenetrationofarectalcancerfollowedbyneoadjuvantchemotherapy AT masubuchimariko fourniersgangrenecausedbypenetrationofarectalcancerfollowedbyneoadjuvantchemotherapy AT takasetsunenobu fourniersgangrenecausedbypenetrationofarectalcancerfollowedbyneoadjuvantchemotherapy AT ichikawatakahiro fourniersgangrenecausedbypenetrationofarectalcancerfollowedbyneoadjuvantchemotherapy AT deguchitomohiro fourniersgangrenecausedbypenetrationofarectalcancerfollowedbyneoadjuvantchemotherapy AT yaguchitoyohisa fourniersgangrenecausedbypenetrationofarectalcancerfollowedbyneoadjuvantchemotherapy |